Headline
The latest stories from AHA Today.
A study published today by Nature found that as many as 5,000 steps per day can slow cognitive decline for individuals with early signs of Alzheimer’s disease. Researchers followed nearly 300 adults with no cognitive impairment for up to 14 years, giving them cognitive assessments and brain scans…
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled lot of 20 mEq potassium chloride injection bags. The notice said the products are incorrectly labeled with a 10 mEq overwrap.
Bill Gassen, Sanford Health president and CEO and AHA chair-elect designate, and Deb Koski, Sanford Health chief philanthropy officer, discuss how a strong culture of giving is extending world-class care across rural communities in the Midwest and beyond.
The AHA’s Division of Health Outcomes and Care Transformation will host a webinar Nov. 10 at 2 p.m. ET, where experts will share strategies to integrate health outcome priorities into strategic plans and leverage data to achieve measurable results.
The AHA commented Nov. 3 on the Centers for Medicare & Medicaid Services’ calendar year 2026 final rule for the physician fee schedule. The rule, released Oct. 31, increases the qualifying alternative payment model participant conversion factor by 3.77% in CY 2026 as compared to CY 2025.
The AHA expressed support Nov. 3 for the bipartisan Home Health Stabilization Act (H.R. 5142), legislation that would establish a two-year pause on planned cuts to home health services from the Centers for Medicare & Medicaid Services.
The Centers for Medicare & Medicaid Services Oct. 31 released its calendar year 2026 final rule for the physician fee schedule.
Individuals and families can enroll in or change their health coverage options through the Health Insurance Marketplace beginning tomorrow through Jan. 15. The AHA offers resources to help people choose the best coverage for themselves and their families.
The AHA and a coalition of organizations urged House and Senate leaders to pass the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act (S. 2761/H.R. 5269).
The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan. 1. The updated website includes a listing of the drug companies and drugs approved by HRSA for…